Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 1/20 | 0.37 |
| ▸ | CA2 | P00918 | 1/20 | 0.37 |
| ▸ | CA4 | P22748 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 4/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.35 |
| ▸ | NPC1 | O15118 | 3/20 | 0.34 |
| ▸ | RAB9A | P51151 | 2/20 | 0.34 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 3/20 | 0.33 |
| ▸ | NOS1 | P29475 | 3/20 | 0.33 |
| ▸ | NOS2 | P35228 | 3/20 | 0.33 |
| ▸ | MT-CO2 | P00403 | 2/20 | 0.33 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.33 |
| ▸ | TSHR | P16473 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.32 |
| ▸ | POLB | P06746 | 1/20 | 0.32 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7703871 | 1.00 | CA1 (0.37) | CA1CA2CA4MAPTHPGD | |
| SCHEMBL7703873 | 1.00 | CA1 (0.37) | CA1CA2CA4MAPTHPGD | |
| SCHEMBL7706418 | 0.97 | KMT2A (0.39) | CA1CA2CA4MAPTHPGD | |
| SCHEMBL1626353 | 0.95 | — | — | |
| SCHEMBL16691801 | 0.95 | — | — | |
| SCHEMBL12333841 | 0.90 | CA1 (0.42) | CA1CA2CA4MAPTHPGD | |
| SCHEMBL120444 | 0.90 | CA1 (0.42) | CA1CA2CA4MAPTHPGD | |
| SCHEMBL22397285 | 0.90 | CA1 (0.42) | CA1CA2CA4MAPTHPGD | |
| SCHEMBL11955 | 0.90 | CA1 (0.42) | CA1CA2CA4MAPTHPGD | |
| SCHEMBL895510 | 0.90 | CA1 (0.42) | CA1CA2CA4MAPTHPGD |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0354920-A1 | AMINO-9,10-SECOSTEROIDS | THE UPJOHN COMPANY (US) | 1990-02-21 | — | — | EP | claimed |
| WO-1988007527-A1 | AMINO-9,10-SECOSTEROIDS | THE UPJOHN COMPANY (US) | 1988-10-06 | — | — | WO | claimed |
| WO-2023141593-A2 | PROCESS FOR SYNTHESIS OF GALBULIMIMA ALKALOID 18 AND COMPOUNDS USEFUL AS OPIOID RECEPTOR ANTAGONISTS AND AGONISTS | THE SCRIPPS RESEARCH INSTITUTE (US) | 2023-07-27 | — | — | WO | disclosed |
| CN-109722455-A | Method, engineering bacteria and the application of microbial fermentation production paddy lactone | 中国科学院天津工业生物技术研究所 | 2019-05-07 | — | — | CN | disclosed |
| CN-105622422-B | A kind of bromo hexahydro indanone compounds and its production and use | 南开大学 | 2017-12-05 | — | — | CN | disclosed |
| CN-105622422-B | A kind of bromo hexahydro indanone compounds and its production and use | 南开大学 | 2017-12-05 | — | — | CN | disclosed |
| WO-2017129113-A1 | BROMOHEXAHYDROINDANONE COMPOUNDS, PREPARATION METHOD FOR SAME, AND USES THEREOF | 南开大学 | 2017-08-03 | — | — | WO | disclosed |
| US-9518076-B2 | Apparatus and process for preparing reactive lignin with high yield from plant biomass for production of fuels and chemicals | WASHINGTON STATE UNIVERSITY (US) | 2016-12-13 | — | — | US | disclosed |
| US-9268226-B2 | Resin, resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20150099868-A1 | APPARATUS AND PROCESS FOR PREPARING REACTIVE LIGNIN WITH HIGH YIELD FROM PLANT BIOMASS FOR PRODUCTION OF FUELS AND CHEMICALS | WASHINGTON STATE UNIVERSITY (US) | 2015-04-09 | — | — | US | disclosed |
| US-8859182-B2 | Resist composition and method for producing resist pattern | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2014-10-14 | — | — | US | disclosed |
| WO-2002087584-A1 | COMBINATIONS OF ALDOSE REDUCTASE INHIBITORS AND CYCLOOXYGENASE-2 INHIBITORS | PFIZER PRODUCTS INC. (US) | 2002-11-07 | — | — | WO | disclosed |
| EP-0921125-B1 | 1,3,8-Triazaspiro[4,5]decan-4-on derivatives | HOFFMANN LA ROCHE (CH) | 2002-01-30 | — | — | EP | disclosed |
| US-6043366-A | USEFUL IN TREATING DISORDERS INVOLVING THE ORPHANIN FQ(A SEVENTEEN AMINO ACID LONG PEPTIDE) RECEPTOR. | HOFFMAN-LA ROCHE INC. (US) | 2000-03-28 | — | — | US | disclosed |
| EP-0921125-A1 | 1,3,8-Triaza-spiro 4,5 decan-4-on derivatives | F. HOFFMANN-LA ROCHE AG (CH) | 1999-06-09 | — | — | EP | disclosed |
| EP-0480871-B1 | Synergistic agents and method for selective control of weeds | CIBA GEIGY AG (CH) | 1995-12-13 | — | — | EP | disclosed |
| WO-1993004070-A1 | SUBSTITUTED ACRYLAMIDO-PENICILLANIC ACID DERIVATIVES | SMITHKLINE BEECHAM, PLC (GB) | 1993-03-04 | — | — | WO | disclosed |
| EP-0421752-A2 | Substituted acrylamido-penicillanic acid derivatives | Beecham Group p.l.c. (GB) | 1991-04-10 | — | — | EP | disclosed |
| US-4784953-A | NOCARDIA WHICH FORMS 4(3-PROPIONIC ACID-5-HYDROXY-7-METHYL INDANONE | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 1988-11-15 | — | — | US | disclosed |
| US-3948903-A | Substituted N-(1,2-dihydro-2-oxonicotinyl)-cephalexins and -cephaloglycins | PARKE, DAVIS & COMPANY (US) | 1976-04-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20150099868-A1 | APPARATUS AND PROCESS FOR PREPARING REACTIVE LIGNIN WITH HIGH YIELD FROM PLANT BIOMASS FOR PRODUCTION OF FUELS AND CHEMICALS | HAAO, HAO2, HAO1 | CA1 4219/4885CA2 3990/4885CA4 3417/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.